Industry News
How does environment-damaged DNA lead to disease?
Nov 26, 2014
Using a technique called time-lapse crystallography, researchers have observed for the first time how the polymerase enzyme inserts nucleotides into strands of DNA. Read More
Why cancer cells grow despite a lack of oxygen
Nov 26, 2014
Healthy cells reduce their growth when there is a lack of oxygen (hypoxia). This makes it even more surprising that hypoxia is a characteristic feature of malignant tumours. Read More
ZS Pharma announces publication of results from phase 3 study of ZS-9 in patients with hyperkalemia
Nov 26, 2014
ZS Pharma have announced the publication of previously unreleased detailed results from the ZS003 study in the New England Journal of Medicine (NEJM). Read More
Researcher turns skin cells into pain sensing neurons
Nov 26, 2014
After more than six years of intensive effort, and repeated failures that made the quest at times seem futile, Harvard Stem Cell Institute (HSCI) researchers at Boston Children's Hospital (BCH) and... Read More
Few cognitive or social setbacks experienced by adult survivors of childhood eye cancer
Nov 26, 2014
Adult survivors of retinoblastoma, a type of eye cancer that usually develops in early childhood, have few cognitive or social problems decades following their diagnosis and treatment. Read More
Half a million new cancer cases each year linked to BMI
Nov 26, 2014
A new global analysis finds proportions of BMI-linked cancers vary across region and gender. North America was found to be the most affected region, with 23% of the global burden. Read More
Newly designed nanoparticles infiltrate, kill cancer cells from within
Nov 26, 2014
UC nanoparticle designs target and treat early stage cancer cells by killing those cells with heat, delivered from inside the cell itself. Read More
New model of follow up for breast cancer patients
Nov 26, 2014
Public health researchers from the University of Adelaide have evaluated international breast cancer guidelines, finding that there is potential to improve surveillance of breast cancer survivors... Read More
Possible cause discovered for failure of targeted liver cancer therapies
Nov 25, 2014
The failure of experimental liver cancer therapies directed specifically against the EGFR protein is presumably the result of insufficiently specific patient selection. Read More
High-dose interleukin-2 effective in metastatic renal cell carcinoma (mRCC) pre-treated with VEGF-targeted therapies
Nov 25, 2014
High-dose interleukin-2 can be effective in selected metastatic renal cell cancer patients pre-treated with VEGF-targeted agents, reveals research presented at the ESMO Symposium on Immuno-Oncology... Read More
Previous Page Next Page